PHIAA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €19.72 |
| 52 Week High | €22.08 |
| 52 Week Low | €15.44 |
| Beta | 0.78 |
| 1 Month Change | 3.13% |
| 3 Month Change | -10.32% |
| 1 Year Change | 26.91% |
| 3 Year Change | -59.32% |
| 5 Year Change | -41.53% |
| Change since IPO | 45.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHIAA | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 7.1% | -1.2% | 1.2% |
| 1Y | 26.9% | -7.4% | -0.3% |
Return vs Industry: PHIAA exceeded the UK Medical Equipment industry which returned -4.9% over the past year.
Return vs Market: PHIAA exceeded the UK Market which returned -0.7% over the past year.
Price Volatility
| PHIAA volatility | |
|---|---|
| PHIAA Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PHIAA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHIAA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHIAA fundamental statistics | |
|---|---|
| Market cap | €17.33b |
| Earnings (TTM) | -€456.00m |
| Revenue (TTM) | €18.17b |
1.0x
P/S Ratio-38.0x
P/E RatioIs PHIAA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIAA income statement (TTM) | |
|---|---|
| Revenue | €18.17b |
| Cost of Revenue | €10.72b |
| Gross Profit | €7.45b |
| Other Expenses | €7.90b |
| Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 40.99% |
| Net Profit Margin | -2.51% |
| Debt/Equity Ratio | 54.8% |
How did PHIAA perform over the long term?
See historical performance and comparison